CIITA is a non-DNA-binding coactivator of major histocompatibility complex (MHC) class II molecules whose high expression is usually associated with enhanced involvement of CD4+ lymphocytes in tumor suppression and a better prognosis (60). This evidence concerns the gene CIITA and neoplasm.